Arrhythmogenic Cardiomyopathy: Diagnosis and Therapy
Submission Deadline: 30 Sep 2022
Guest Editor
Special Issue Information
Dear Colleagues,
In arrhythmogenic cardiomyopathy, characterized by fibrofatty replacement of the myocardium, diagnostic efforts are difficult and many different steps are required to provide an accurate diagnosis.
In case of diagnosis standard ECG, echocardiography, right ventricular angiography and electrophysiological examination can provide strong diagnostic evidence.
The most relevant diagnostic method is cardiac MRI with late enhancement. Each of these diagnostic methods should be reported in advance.
Therapeutic options include ICD implantation, ablation of ventricular tachycardia using an endocardial or epicardial approach, pharmacological approaches (amiodarone, flecainide, and beta-blockers), and most importantly the management of heart failure. In nearly 40% of cases, different forms of arrhythmogenic cardiomyopathy (arrhythmogenic biventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy) result in severe heart failure that can only be managed with early prophylactic treatment triggered by the genetic findings (phospholamban, lamin A/C, and filamin C mutations).
I am pleased to invite you to submit original manuscripts on the subject of “Arrhythmogenic cardiomyopathy: diagnosis and therapy” for this Special Issue. Full papers, communications, and comprehensive reviews are welcome.
Prof. Stefan Peters
Guest Editor
Keywords
- Arrhythmogenic cardiomyopathy
- Therapy
- Diagnosis
- Flecainide
- ICD implantation
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (4)
New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria
Rev. Cardiovasc. Med. 2022, 23(10), 335; https://doi.org/10.31083/j.rcm2310335
(This article belongs to the Special Issue Arrhythmogenic Cardiomyopathy: Diagnosis and Therapy)
Catheter Ablation in Arrhythmic Cardiac Diseases: Endocardial and Epicardial Ablation
Rev. Cardiovasc. Med. 2022, 23(9), 324; https://doi.org/10.31083/j.rcm2309324
(This article belongs to the Special Issue Arrhythmogenic Cardiomyopathy: Diagnosis and Therapy)
A Territory-Wide Study of Arrhythmogenic Right Ventricular Cardiomyopathy Patients from Hong Kong
Rev. Cardiovasc. Med. 2022, 23(7), 231; https://doi.org/10.31083/j.rcm2307231
(This article belongs to the Special Issue Arrhythmogenic Cardiomyopathy: Diagnosis and Therapy)
Saw-Tooth Cardiomyopathy: the Evidence in the First Decade
Rev. Cardiovasc. Med. 2022, 23(4), 138; https://doi.org/10.31083/j.rcm2304138
(This article belongs to the Special Issue Arrhythmogenic Cardiomyopathy: Diagnosis and Therapy)